GKT137831 is primarily investigated for its potential therapeutic applications, particularly in the treatment of diseases associated with oxidative stress and inflammation. It is known to inhibit NADPH oxidase enzymes, which play a significant role in the generation of reactive oxygen species (ROS). By targeting these enzymes, it may help mitigate the damage caused by excessive ROS production in conditions such as diabetes, cardiovascular diseases, and chronic inflammatory disorders. Additionally, it is being studied for its potential in treating fibrotic diseases, as reducing oxidative stress can slow the progression of tissue scarring. Its application in cancer research is also emerging, as controlling ROS levels may influence tumor growth and metastasis. Overall, GKT137831 represents a promising candidate for addressing a range of oxidative stress-related pathologies.